Omada Health, INC Form 4 insider transactions

Omada Health CEO Sean P. Duffy reported the acquisition of 323,529 restricted stock units and updated his beneficial ownership.

Omada Health CEO Sean P. Duffy exercised expiring stock options and subsequently sold a portion of the acquired common stock in January 2026.

Omada Health's Director, Jonathan D. Root, was granted 915 restricted stock units as part of the company's non-employee director compensation program.

Omada Health Director Trevor Fetter reported the acquisition of 991 common shares through restricted stock units as part of his compensation.

Omada Health, Inc. Director Jeryl L. Hilleman received a grant of 1,601 restricted stock units on January 5, 2026, as part of the company's non-employee director compensation program.

Omada Health President Wei-Li Shao sold 5,618 shares of common stock at a weighted average price of $16.1349 per share under a pre-arranged 10b5-1 trading plan.

Omada Health Director Jeryl L. Hilleman filed an amended Form 4 to correct an overstatement of 45 restricted stock units in a previous filing.

Omada Health's Chief Financial Officer, Steven L. Cook, sold 4,211 shares of common stock for $15.3657 per share under a pre-arranged 10b5-1 trading plan.

Omada Health CEO Sean P. Duffy sold 9,266 shares of common stock for $15.3657 per share under a pre-arranged 10b5-1 trading plan.

Omada Health's President, Wei-Li Shao, disposed of 1,843 common shares at $17.49 each to cover tax liabilities.

Omada Health CEO Sean P. Duffy disposed of 4,413 shares of common stock to cover tax withholding obligations at a price of $17.49 per share.

Omada Health's Chief Financial Officer, Steven L. Cook, disposed of 2,006 shares of common stock to cover tax withholding obligations.

Omada Health Director Jonathan D. Root reports an in-kind distribution of common stock from USVP X Funds, resulting in a change in his beneficial ownership.

Jonathan D. Root, a Director at Omada Health, Inc., acquired 657 restricted stock units as part of his compensation.

Omada Health, Inc. Director Trevor Fetter was granted 712 restricted stock units as part of the company's non-employee director compensation program.

Jeryl L. Hilleman, a director at Omada Health, Inc., acquired 1,126 restricted stock units as part of the company's non-employee director compensation program.

Omada Health's Chief Financial Officer, Steven L. Cook, disposed of 2,006 shares of common stock at $24.28 per share to cover tax withholding obligations.

Omada Health CEO Sean P. Duffy disposed of 4,413 shares of common stock to cover tax withholding obligations at a price of $24.28 per share.

Omada Health's President, Wei-Li Shao, disposed of 2,407 shares of common stock to cover tax withholding obligations at a price of $24.28 per share.

Omada Health, Inc. Director Jeryl L. Hilleman reported the acquisition of 376 restricted stock units (RSUs) on July 5, 2025, bringing her total direct beneficial ownership to 10,112 shares of Common Stock.

Omada Health, Inc. Director Jonathan D. Root was granted 237 restricted stock units as part of his compensation, increasing his direct beneficial ownership to 9,973 shares.

Omada Health, Inc. Director Trevor Fetter acquired 257 shares of common stock in the form of restricted stock units as part of the company's non-employee director compensation program.

Omada Health, Inc. director Julie D. Klapstein was granted 9,736 restricted stock units (RSUs) on June 5, 2025, which are set to fully vest on the first anniversary of the grant date.

Revelation Alpine, LLC and affiliated entities have converted over 4.1 million shares of Omada Health preferred stock into common stock, increasing their beneficial ownership to over 5.2 million common shares, in a transaction immediately preceding the company's initial public offering.

Multiple Revelation entities, significant shareholders in Omada Health, Inc., have converted their preferred stock holdings into common stock immediately prior to the company's initial public offering.

Jonathan D. Root, a Director at Omada Health, Inc., has reported substantial changes in his beneficial ownership of the company's common stock, including the conversion of millions of preferred shares into common stock immediately prior to the company's initial public offering and the grant of restricted stock units.

Omada Health Director Trevor Fetter has reported the acquisition of restricted stock units and the conversion of preferred stock into common shares, totaling a significant change in his beneficial ownership.

Omada Health, Inc. Director Anne Beal was granted 9,736 restricted stock units (RSUs) on June 5, 2025, which will fully vest on the first anniversary of the grant date.

Omada Health, Inc. Director Adam Stavisky was granted 9,736 restricted stock units (RSUs) on June 5, 2025, as part of his compensation.

Omada Health, Inc. disclosed that Director Sachin H. Jain was granted 9,736 restricted stock units (RSUs) on June 5, 2025, which will fully vest on the first anniversary of the grant date.